Billy Joel says he can't perform on his neurologist's advice and needs further testing to determine whether he can return to ...
Billy Joel says he can't perform on his neurologist's advice and needs further testing to determine whether he can return to ...
Practical framework helps researchers select optimal assay platforms amid limited sample volume,low-abundance targets,instrument constraints and budget pressure HUSTON, TX, UNITED STATES, October 14, ...
Legendary singer Billy Joel said he can no longer drive or perform due to his battle with Normal Pressure Hydrocephalus.
Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a ...
Clinical Trials Arena on MSN
Arrowhead’s Alzheimer’s disease drug reduces tau in Phase I/IIa trial
Arrowhead is now moving its tau-targeting therapy from healthy volunteers to Alzheimer’s disease patients.
Exactly two years ago. In October 2024, I had a sports accident.I was doing light mass sparring in kickboxing, and even ...
A case report in the Journal of Neurology documents systemic and central nervous system hypofucosylation in a child with ...
A new study shows that sequencing tumor DNA in ascites, pleural fluid, cerebrospinal fluid, and pericardial effusions can ...
Third drug candidate from Tenvie’s product engine to enter clinical development in 2026TNV313 joins TNV262 to give Tenvie two clinical-stage, ...
Learn about innovative treatments and compassionate care at Tulane Medicine for individuals suffering from trigeminal ...
Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results